Discussion on the Relationship between Intestinal Flora Dysbiosis and Metabolic Fatty Liver Disease based on the Theory of "Spleen is the Guard"
DOI:
https://doi.org/10.53469/jcmp.2024.06(12).19Keywords:
Metabolism-associated fatty liver disease, Spleen is the guard, Intestinal flora dysbiosisAbstract
"Spleen is the guard" means that the spleen has the function of resisting external evils and warming the body. "The spleen loses its guard". When the spleen is weak, phlegm, turbidity and blood stasis will invade the body and develop into metabolism-associated fatty liver disease (MAFLD). Dysregulation of intestinal flora can lead to the occurrence and development of MAFLD, so we can treat MAFLD by regulating intestinal flora as the target.
References
Zhang Li, Ji Guang. Expert consensus on Traditional Chinese Medicine diagnosis and treatment of non-alcoholic fatty liver disease (2023) [J]. Chinese Journal of Integrated Traditional and Western Medicine on Digestion, 2024, 32(01):1-7.
Riazi K, Azhari H, Charette J H, et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis[J]. Lancet Gastroenterol Hepatol, 2022, 7(9):851-861.
Zhou J, Zhou F, Wang W, et al. Epidemiological Features of NAFLD From 1999 to 2018 in China[J]. Hepatology, 2020, 71(5):1851-1864.
Adak A, Khan M R. An insight into gut microbiota and its functionalities[J]. Cell Mol Life Sci, 2019, 76(3):473-493.
Alghamdi W, Mosli M, Alqahtani S A. Gut microbiota in MAFLD: therapeutic and diagnostic implications[J]. Ther Adv Endocrinol Metab, 2024, 15:1839355079.
Li Xiaofei, Li Jinhong, Sun Yuefeng, et al. The theoretical basis of treating rotavirus enteritis with Wujiajian Zhengqi Powder based on the theory of "spleen defending" [J]. Lishizhen Medicine and Materia Medica Research, 2023, 34(08):1935-1936.
Liu Changxing, Guo Xinyi, Wang Boyu, et al. The relationship between intestinal microecological imbalance and heart failure based on the theory of "spleen as the guardian" [J]. Chinese Journal of Arteriosclerosis, 2024, 32(03):263-270.
Zhang Pengkun, Jin Zhe, Tigerson Yang. Discussion on the Role of Intestinal Flora in Autoimmune Thyroiditis based on the Principle of "Spleen as the Guard" [J]. Clinical Journal of Traditional Chinese Medicine, 2024, 36(05):838-843.
Zhang Zhisu, Zhu Feng, Zhang Shiwu. Expression Levels of Serum TLR4, IL-17 and IL-23 in Patients with Nonalcoholic Fatty Liver Disease and Their Correlation with Gut Microbiota[J]. Chinese Journal of Microcirculation, 2024, 34(03):71-75.
Zhao Xiangyun, Liang Huijie, Lu Shifa, et al. Effect of Lactobacillus rhamnosus on intestinal flora and serum factors in mice with nonalcoholic fatty liver disease[J]. Journal of Pathogen Biology, 2024, 19(11):1283-1289.
Li Qianrong, Kou Xiaoni. Research progress of intestinal flora-bile acid axis in hepatocellular carcinoma associated with nonalcoholic fatty liver disease[J]. Modern Interventional Diagnosis and Treatment in Gastroenterology, 2024, 29(06):754-759.
Song Q, Zhang X. The Role of Gut-Liver Axis in Gut Microbiome Dysbiosis Associated NAFLD and NAFLD-HCC[J]. Biomedicines, 2022, 10(3).
Wang Mengyi, Wang Zhuo, Liu Yang. Research progress on the regulation and mechanism of lipid metabolism by intestinal flora[J]. Microbiology Bulletin, 2024:1-17.
Tang Yinpei, Zhu Zhengwang, Wang Bing, et al. Mechanism of Traditional Chinese Medicine in Regulating Gut Microbiota in Treating Metabolic-associated Fatty Liver Disease[J]. Chinese Journal of Experimental Traditional Medical Formulae, 2024, 30(24):272-278.
Shan Pengtao, Ge Wenjing, Fu Junmin, et al. The regulation and target of nuclear receptors PPAR, FXR and LXR in nonalcoholic fatty liver disease[J]. Chemistry of Life, 2023, 43(08):1237-1245.
Ren Jing, Li Yusi, Li Huimin, et al. Treatment of Diabetic Constipation from Spleen Deficiency Based on Intestinal Flora[J]. World Journal of Integrated Traditional and Western Medicine, 2024, 19(02):399-403.
Jia Chenchen, Yue Rong, Xiang Wenwen, et al. Effect of Modified Xiaoyao Powder on intestinal barrier and intestinal flora in mice with metabolic associated fatty liver disease based on "gut-liver axis" [J]. China Journal of Chinese Materia Medica, 2024.
Zhou Fang, Yuan Qingliang, Yang Jianmei, et al. Efficacy observation of Shugan Huazhuo yin on non-alcoholic fatty liver disease with syndrome of stagnation of liver qi and deficiency of spleen[J]. Shanxi Journal of Traditional Chinese Medicine, 2024, 40(07):11-13.
Du Pengyun, Liu Xiaoyu, Xu Jianing, et al. Effects of Intermittent Fasting Combined with the Decoction of Ling-gui-zhu-gan and Prebiotics on Mice with Non-alcoholic Fatty Liver Disease[J]. Progress in Modern Biomedicine, 2024, 24(19):3609-3615.
Rebecca, Song Li. Effects of Jiawei Yinchenhao Decoction combined with acupuncture on intestinal flora, oxidative stress and cytokines in patients with nonalcoholic fatty liver[J]. Modern Journal of Integrated Traditional Chinese and Western Medicine, 2023, 32(08):1119-1122.
Yang Jiayao, Shi Zhaohong, Ma Wei, et al. Effect of Fuzi Lizhong decoction in reducing liver injury of rats with non-alcoholic fatty liver via activating AMPK and suppressing NF-κBp65 pathway[J]. China Journal of Chinese Materia Medicae, 2018, 43(15):3176-3183.
Cheng Shiyu, Chen Xiaoyun, Tan Xiyang, et al. Effects of Exocarpium Citri Rubrum Extract on Intestinal Flora and Chinese Medicine Constitution in Non-Alcoholic Fatty Liver Disease with Obesity:A Randomized Controlled Trial[J]. Chinese Journal of Integrated Traditional and Western Medicine, 2024, 44(10):1206-1214.
Chen Erhua, Liu Xiang, Yang Yue, et al. Effects of Schisandra chinensis aqueous extract on gut microbiota of NAFLD mice[J]. China Food Additives, 2024, 35(05):36-45.
Yuan Man, Xie Jinli, Yu Lixia, et al. REGULATION AND HEALTH EFFECTS OF QUERCETIN ON GUT MICROBIOTA[J]. Acta Nutrimenta Sinica, 2023, 45(01): 98-103.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Hanwen Xu, Hui Ding
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
